ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $9,766,000 | -53.6% | 27,889 | -84.9% | 1.12% | -54.8% |
| Q3 2019 | $21,041,000 | -29.4% | 184,631 | -12.2% | 2.48% | -15.1% |
| Q2 2019 | $29,784,000 | -11.8% | 210,372 | -22.2% | 2.93% | -35.1% |
| Q1 2019 | $33,775,000 | +21.2% | 270,548 | -6.8% | 4.52% | +7.4% |
| Q4 2018 | $27,878,000 | +36.5% | 290,181 | +7.7% | 4.20% | +195.0% |
| Q3 2018 | $20,426,000 | +21.9% | 269,325 | +33.1% | 1.42% | +21.8% |
| Q2 2018 | $16,762,000 | +25.5% | 202,293 | +21.9% | 1.17% | +10.9% |
| Q1 2018 | $13,354,000 | +139.6% | 166,011 | +88.1% | 1.06% | +193.9% |
| Q4 2017 | $5,573,000 | – | 88,269 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |